SSRI is testing its support down to 26. We got a new Red Buy signal tonight.
When looking for these red Buys we like to see supporting evidece such as a
the stock being at its rising 50-day ma (blue). A recovery to 30-31 seems likely
and then backing and filling as in last August. All these Buy signals have yielded a total
of 27% for the last year. The red short sales taken at the next day's opening have
gained 54% for the last year. The stock shows a declining Opening and Closing Power.
Volume rose today. But the volume at the low last August was twice as high.
If I were buying this I would wait for a strong close or a closer testing of 26. Headroom
is needed for a long profit. And 30 will be a barrier now that it has been closed below.
(C) 2008, April 23, 2008 - William Schmidt, Ph.D. www.tigersoft.com
